Page 47 - 76_03
P. 47

VOL. 76 (3), 327-342, 2010  ANTITUMORAL ACTIVITY OF ONCOLYTIC VACCINIA VIRUS...

 9. Lee, S. B., Green, S. R., Mathews, M. B. & Esteban, M. (1994) Activation of the
        double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the
        absence of its dsRNA binding domain. Proc. Natl. Acad. Sci. USA. 91(22): 10551-
        10555.

10. Rodriguez, J. F., Rodriguez, D., Rodriguez, J. R., McGowan, E. B. & Esteban,
        M. (1988) Expression of the firefly luciferase gene in vaccinia virus: a highly
        sensitive gene marker to follow virus dissemination in tissues of infected ani-
        mals. Proc. Natl. Acad. Sci. USA. 85(5): 1667-1671.

11. Lee, S. B., Melkova, Z., Yan, W., Williams, B. R., Hovanessian, A. G. & Esteban,
        M. (1993) The interferon-induced double-stranded RNA-activated human p68
        protein kinase potently inhibits protein synthesis in cultured cells. Virology.
        192(1): 380-385.

12. Williams, B. R. (1999) PKR; a sentinel kinase for cellular stress. Oncogene.
        18(45): 6112-6120.

13. Kirn, D. H. & Thorne, S. H. (2009) Targeted and armed oncolytic poxviruses: a
        novel multi-mechanistic therapeutic class for cancer. Nat. Rev. Cancer. 9(1): 64-
        71.

14. Guo, Z. S., Thorne, S. H. & Bartlett, D. L. (2008) Oncolytic virotherapy: molec-
        ular targets in tumor-selective replication and carrier cell-mediated delivery of
        oncolytic viruses. Biochim. Biophys. Acta. 1785(2): 217-231.

15. Gilbert, P. A. & McFadden, G. (2006) Poxvirus cancer therapy. Recent Pat.
        Antiinfect. Drug Discov. 1(3): 309-321.

16. Gil, J., Alcami, J. & Esteban, M. (1999) Induction of apoptosis by double-strand-
        ed-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryot-
        ic translation initiation factor 2 and NF-kappaB. Mol. Cell Biol. 19(7): 4653-4663.

17. Gil, J., Alcami, J. & Esteban, M. (2000) Activation of NF-kappa B by the dsRNA-
        dependent protein kinase, PKR involves the I kappa B kinase complex.
        Oncogene. 19(11): 1369-1378.

18. Balachandran, S. & Barber, G. N. (2007) PKR in innate immunity, cancer, and
        viral oncolysis. Methods Mol. Biol. 383: 277-301.

19. Guerra, S., Lopez-Fernandez, L. A., Garcia, M. A., Zaballos, A. & Esteban, M.
        (2006) Human gene profiling in response to the active protein kinase, interfer-
        on-induced serine/threonine protein kinase (PKR), in infected cells. Involvement
        of the transcription factor ATF-3 IN PKR-induced apoptosis. J. Biol. Chem.
        281(27): 18734-18745.

20. Yoon, C. H., Lee, E. S., Lim, D. S. & Bae, Y. S. (2009) PKR, a p53 target gene,
        plays a crucial role in the tumor-suppressor function of p53. Proc. Natl. Acad.
        Sci. USA. 106(19): 7852-7857.

21. Lee, J. H., Roh, M. S., Lee, Y. K., Kim, M. K., Han, J. Y., Park, B. H., et al. (2010)
        Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus ex-
        pressing human GM-CSF following intravenous administration in a rabbit tu-
        mor model. Cancer Gene Ther. 17(2): 73-79.

22. Frentzen, A., Yu, Y. A., Chen, N., Zhang, Q., Weibel, S., Raab, V., et al. (2009)
        Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus
        significantly enhances antitumor therapy. Proc. Natl. Acad. Sci. USA. 106(31):
        12915-12920.

                            341
   42   43   44   45   46   47   48   49   50   51   52